Medicare wonâ??t pay for genetic tests to determine patientsâ?? best dose of the blood thinner warfarin, discovered at UW-Madison and named after the Wisconsin Alumni Research Foundation, or WARF.
The Centers for Medicare and Medicaid Services said Monday there isn’t enough evidence that the tests improve patientsâ?? health â?? though the agency agreed to pay for tests in studies that could lead to more such evidence.